Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 6 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

AMN Healthcare Services is currently experiencing strong financial performance as evidenced by their Q1 results where they exceeded consensus revenue and EBITDA by 12% and 35%, respectively. The company's revenue growth potential is further supported by its potential to begin a return to its more normalized growth algorithm in the future. While there are potential risks and challenges related to their business, the company has a strong track record, and their recent acquisitions could also contribute to their future growth.

Bears say

AMN Healthcare Services is facing headwinds in its language services segment due to competitive pressures, resulting in a decline in revenue and margin. Additionally, the company's labor disruption revenue is expected to plateau in 2026, potentially hampering future growth. Despite positive developments in Nurse and Allied volumes and bill rates, the stock's current valuation, trading at 10.5x and 9.6x next twelve months (NTM) and 2027 EBITDA estimates respectively, is higher than its average forward EBITDA valuation of 11.8x from 2016 to 2019, when the company was not facing pandemic-related challenges.

AMN has been analyzed by 6 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Hold based on their latest research and market trends.

According to 6 analysts, AMN has a Hold consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.